Prime Medicine, Inc. (PRME) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q3 EPS of ($0.32), $0.11 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1 million, versus $0 reported last year.
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
- AG Mortgage Investment Trust (MITT) Misses Q2 EPS by 3c
- monday.com Ltd. (MNDY) Tops Q2 EPS by 37c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
